NASH/MASH Deal Benchmarks 2026
Market Analysis
The NASH/MASH therapeutic landscape was transformed by resmetirom's (Rezdiffra) FDA approval in March 2024 — the first approved therapy for metabolic dysfunction-associated steatohepatitis. This validated the category and unlocked a wave of licensing deals. Madrigal Pharmaceuticals' market cap exceeded $7B on approval, setting the commercial benchmark for the class.
Phase 2 MASH small molecule deals command median upfront payments of $654M, with total deal values of $3.1B. GLP-1-based MASH approaches (leveraging semaglutide's MASH data) push even higher at $4.7B total value, reflecting the dual obesity/MASH opportunity.
Key deal drivers include fibrosis improvement data (F2-F3 reversal), combination strategies with GLP-1 agonists, and the massive undiagnosed patient population (estimated 6-8M in the US alone). Efruxifermin (FGF21 agonist) was acquired by Novo Nordisk for $1.4B, while survodutide (GLP-1/glucagon dual agonist) is being developed by Boehringer Ingelheim in a $1.6B partnership with Zealand.
Full Benchmark Analysis
Complete deal term ranges, comparable transactions, and negotiation insights.
Start 7-Day Free Trial$299/mo after trial · Cancel anytime
Customize these benchmarks for your asset
Adjust phase, modality, competitive position, and 10+ other parameters.
Frequently Asked Questions
What are MASH deals worth after resmetirom approval?
How do MASH deal terms compare to obesity deals?
What endpoints matter most for MASH deal valuations?
Full Benchmark Analysis
Complete deal term ranges, comparable transactions, and negotiation insights.
Start 7-Day Free Trial$299/mo after trial · Cancel anytime
Ready to Calculate Your Deal Terms?
Get instant, customized benchmarks based on real market data from 1,600+ biopharma licensing deals.
Start CalculatingNeed the full deal landscape?
The Deal Intelligence Brief covers every modality and deal structure for this indication — 52 deal calculations, AI strategic narrative, comparable transactions, partner matching, and white-label branding. Delivered in 24 hours.